COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05633472


Column Value
Trial registration number NCT05633472
Full text link
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

https://clinicaltrials.gov/show/NCT05633472

First author
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Jiu-Yao Wang, MD

Contact
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

aim.cmuh@gmail.com

Registration date
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

2022-12-01

Recruitment status
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Recruiting

Study design
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

inclusion criteria: children aged 0-18 years the child sought/needed primary or secondary medical care for covid-19 laboratory (rt-pcr, covid-19 antigen tests or sars-cov-2 antibody testing) or physician confirmed sars-cov-2 infection based on classic clinical symptoms and/or ground-glass opacification on ct imaging. 28 days - 3 months from the onset of covid-19 symptoms parent's/carer's/guardians consent to participate

Exclusion criteria
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

recruit patients who have used antibiotics, systemic steroids, and immunosuppressants in the previous month. patients with c1 esterase inhibitor deficiency, lymphocytopenia, thrombocytopenia, severe diseases involving heart, liver, or kidney, metabolic disease, or autoimmune disease.

Number of arms
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

China Medical University Hospital

Inclusion age min
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

0

Inclusion age max
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

18

Countries
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Taiwan

Type of patients
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

150

primary outcome
Last imported at : Dec. 9, 2022, 4 a.m.
Source : ClinicalTrials.gov

Allergen-specific immunoglobulin E (IgE);Levels of vitamin D;Levels of vitamin D;Microbiome;Microbiome;Single nucleotide polymorphism of vitamin D receptor and vitamin D binding protein;Total immunoglobulin E (IgE);Total immunoglobulin E (IgE)

Notes
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Dec. 2, 2022, 4 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "nan", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]